Trexquant Investment LP Boosts Stock Holdings in Oscar Health, Inc. $OSCR

Key Points

• Trexquant Investment LP increased its holdings in Oscar Health, acquiring an additional 397,962 shares, bringing its total to 677,845 shares, valued at approximately $8.89 million.
• Several institutional investors are actively buying and selling shares of Oscar Health, with about 75.70% of the stock currently held by these investors.
• Analysts have recently downgraded Oscar Health’s stock ratings, with a consensus rating of "Strong Sell" and a target price of $12.07.

Trexquant Investment LP increased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 142.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 677,845 shares of the company's stock after acquiring an additional 397,962 shares during the quarter. Trexquant Investment LP owned about 0.27% of Oscar Health worth $8,887,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of OSCR. Larson Financial Group LLC raised its stake in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after acquiring an additional 2,512 shares in the last quarter. CWM LLC raised its stake in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of Oscar Health by 484.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after acquiring an additional 2,854 shares in the last quarter. Cliffwater LLC bought a new position in shares of Oscar Health during the 1st quarter worth approximately $58,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Oscar Health during the 1st quarter worth approximately $59,000. Institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

NYSE OSCR traded up $0.73 on Thursday, hitting $18.41. 22,457,918 shares of the company's stock traded hands, compared to its average volume of 16,745,822. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The firm's 50-day moving average price is $15.80 and its two-hundred day moving average price is $14.99. The firm has a market capitalization of $4.76 billion, a PE ratio of -22.73 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. During the same period in the previous year, the business posted $0.20 EPS. The business's quarterly revenue was up 29.0% compared to the same quarter last year. As a group, analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. UBS Group reissued a "sell" rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their target price for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Four analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.